Synovus Financial’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-3,918
| Closed | -$358K | – | 839 |
|
|
2023
Q2 | $358K | Sell |
3,918
-175
| -4% | -$14.4K | ﹤0.01% | 689 |
|
|
2023
Q1 | $301K | Buy |
4,093
+265
| +7% | +$22.9K | ﹤0.01% | 720 |
|
|
2022
Q4 | $320K | Sell |
3,828
-2,599
| -40% | -$234K | ﹤0.01% | 718 |
|
|
2022
Q3 | $618K | Buy |
6,427
+258
| +4% | +$30.8K | 0.01% | 525 |
|
|
2022
Q2 | $652K | Buy |
6,169
+241
| +4% | +$30.8K | 0.01% | 521 |
|
|
2022
Q1 | $1.03M | Buy |
5,928
+495
| +9% | +$74K | 0.01% | 429 |
|
|
2021
Q4 | $863K | Buy |
5,433
+416
| +8% | +$66.9K | 0.01% | 497 |
|
|
2021
Q3 | $746K | Buy |
5,017
+1,586
| +46% | +$330K | 0.01% | 507 |
|
|
2021
Q2 | $831K | Buy |
3,431
+7
| +0.2% | +$1.84K | 0.01% | 483 |
|
|
2021
Q1 | $913K | Buy |
3,424
+61
| +2% | +$17.2K | 0.01% | 410 |
|
|
2020
Q4 | $989K | Buy |
3,363
+39
| +1% | +$10K | 0.01% | 366 |
|
|
2020
Q3 | $783K | Buy |
3,324
+459
| +16% | +$104K | 0.01% | 389 |
|
|
2020
Q2 | $569K | Buy |
2,865
+1,436
| +100% | +$268K | 0.01% | 433 |
|
|
2020
Q1 | $265K | Buy |
+1,429
| New | +$254K | ﹤0.01% | 702 |
|
|
2018
Q4 | – | Sell |
-24
| Closed | -$3K | – | 1389 |
|
|
2018
Q3 | $3K | Buy |
+24
| New | +$2.65K | ﹤0.01% | 1289 |
|
|
2017
Q1 | – | Sell |
-1,500
| Closed | -$64K | – | 1097 |
|
|
2016
Q4 | $64K | Hold |
1,500
| – | – | ﹤0.01% | 686 |
|
|
2016
Q3 | $71K | Hold |
1,500
| – | – | ﹤0.01% | 655 |
|
|
2016
Q2 | $76K | Hold |
1,500
| – | – | ﹤0.01% | 611 |
|
|
2016
Q1 | $73K | Hold |
1,500
| – | – | ﹤0.01% | 619 |
|
|
2015
Q4 | $59K | Hold |
1,500
| – | – | ﹤0.01% | 643 |
|
|
2015
Q3 | $57K | Hold |
1,500
| – | – | ﹤0.01% | 594 |
|
|
2015
Q2 | $60K | Hold |
1,500
| – | – | ﹤0.01% | 590 |
|
|
2015
Q1 | $40K | Hold |
1,500
| – | – | ﹤0.01% | 665 |
|
|
2014
Q4 | $44K | Hold |
1,500
| – | – | ﹤0.01% | 657 |
|
|
2014
Q3 | $30K | Hold |
1,500
| – | – | ﹤0.01% | 680 |
|
|
2014
Q2 | $25K | Hold |
1,500
| – | – | ﹤0.01% | 675 |
|
|
2014
Q1 | $22K | Hold |
1,500
| – | – | ﹤0.01% | 687 |
|
|
2013
Q4 | $22K | Hold |
1,500
| – | – | ﹤0.01% | 657 |
|
|
2013
Q3 | $26K | Hold |
1,500
| – | – | ﹤0.01% | 614 |
|
|
2013
Q2 | $17K | Buy |
+1,500
| New | +$17.2K | ﹤0.01% | 655 |
|
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Synovus Financial's AMED Position: Q3 2023 in Review
Synovus Financial sold out of Amedisys (AMED) in Q3 2023, closing a stake of 3,918 shares — an estimated $358K sold.
Synovus Financial first reported a position in AMED in Q2 2013 and held it in 30 quarters. The position peaked at $1.03M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Synovus Financial reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Synovus Financial sold 3,918 Amedisys shares in Q3 2023, an estimated $358K.
- Synovus Financial first reported a position in Amedisys in Q2 2013 and held it in 30 quarters.
- Synovus Financial's Amedisys position peaked at $1.03M in Q1 2022.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Synovus Financial's 13F filing for Q3 2023, filed 13 Nov 2023.